Director/PDMR Shareholding

RNS Number : 9101E
Morgan Advanced Materials PLC
03 March 2020
 

1

Details of the person discharging managerial responsibilities / persons closely associated

a)

Name

Pete Raby

2

Reason for the notification

a)

Position/status

PDMR - CEO 

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Morgan Advanced Materials plc

b)

LEI

I4K14LL95N2PHDL7EG85

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each

 

GB0006027295

b)

Nature of the transaction

Vesting of the 2017 award under the Deferred Bonus Plan and sale of sufficient shares in order to satisfy Income Tax and National Insurance Contributions required to be withheld on release. Retained shares transferred to Candice Raby (spouse of CEO).

c)

Price(s) and volume(s)

 

No. of shares acquired

No. of shares sold

Sale price per share

No. of shares retained

24,228

11,428

GBP 2.88

12,800

d)

Aggregated information

-  Aggregated volume

-  Price

N/A

e)

Date of the transaction

2020-03-03

 

f) 

Place of the transaction

London Stock Exchange (XLON)

 

 

 

 

 

 

 

1

Details of the person discharging managerial responsibilities / persons closely associated

a)

Name

Peter Turner

2

Reason for the notification

a)

Position/status

PDMR- CFO

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Morgan Advanced Materials plc

b)

LEI

I4K14LL95N2PHDL7EG85

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25p each

 

GB0006027295

b)

Nature of the transaction

Vesting of the 2017 award under the Deferred Bonus Plan and sale of sufficient shares in order to satisfy Income Tax and National Insurance Contributions required to be withheld on release.

c)

Price(s) and volume(s)

 

No. of shares acquired

No. of shares sold

Sale price per share

No. of shares retained

16,900

7,972

GBP 2.88

8,928

d)

Aggregated information

-  Aggregated volume

-  Price

N/A

e)

Date of the transaction

2020-03-03

 

f) 

Place of the transaction

London Stock Exchange (XLON)

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFLFFDVTIVIII
UK 100